Digilant Partners with Lasso to Bolster its Omnichannel Healthcare and Pharma Advertising Solutions

Omnichannel advertising services company Digilant announced a strategic partnership with Lasso, the world’s most comprehensive platform for healthcare marketing and analytics, to further strengthen its healthcare and pharma advertising solutions.

Marketing Technology News:  Avtex Wins 2021 Pandemic Tech Innovation Award

The new partnership will combine unmatched reach and physician-level reporting with best-in-class omnichannel media execution, delivering the most powerful advertising solution for healthcare and pharma marketers that spans programmatic, email, social and Connected TV (CTV).

With a comprehensive identity graph of the US population and access to more than 40 billion medical claims and RX transactions, Lasso enables healthcare marketers to match and target physicians one-to-one and patients deterministically across all digital channels. This level of granular targeting allows the Digilant team to execute media campaigns with greater efficiency and drive engagement rates that are 2X the industry standard.

Marketing Technology News:  MarTech Interview with Gary Burtka, VP U.S. Operations at RTB House

“Along with the fast-growing healthcare sector and focus on consumer privacy, the healthcare and pharma industries need access to accurate and privacy-safe data and insights more than ever,” said Raquel Rosenthal, CEO of Digilant. “We are thrilled to have found a partner like Lasso who is leading the charge for healthcare marketers and creating opportunities for impactful connections between brands, physicians and patients.”

“Today, healthcare and pharma marketers need to maximize every dollar spent,” said Mike DiNorscio, Co-Founder and Chief Revenue Officer at Lasso. “Our partnership with Digilant demonstrates our commitment to providing marketers with best-in-class tools that drastically improve the reach, relevancy and ROI of their digital campaigns.”

Brought to you by
For Sales, write to: contact@martechseries.com
Copyright © 2024 MarTech Series. All Rights Reserved.Privacy Policy
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.